Skip to content

Clinical trials

Phase 3 Ovarian Neoplasms trials in Switzerland

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Ovarian Neoplasms Phase: Phase 3 Country / region: Switzerland Clear all

20 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20091
20102
20112
20132
20151
20163
20182
20191
20252
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed12
Recruiting3
Terminated3
Active, not recruiting1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Amgen2
Pfizer2
AGO Research GmbH1
AstraZeneca1
EBMT Solid Tumors Working Party1
Eli Lilly and Company1
European Organisation for Research and Treatment of Cancer - EORTC1
Hoffmann-La Roche1
ImmunoGen, Inc.1
Incyte Corporation1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Ovarian Neoplasms20
Fallopian Tube Neoplasms5
Carcinoma, Ovarian Epithelial4
Peritoneal Neoplasms2
Endometrial Neoplasms1
Fibrosarcoma1
Hemangiosarcoma1
Histiocytoma, Malignant Fibrous1
Kidney Neoplasms1
Leiomyosarcoma1

Trials

Showing 1 to 20 of 20. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.